Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Hoffmann-La Roche is conducting a Phase 1/2 study to evaluate the safety and efficacy of multiple treatment combinations in patients with estrogen receptor-posi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING